Filing Details
- Accession Number:
- 0001209191-19-054497
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-30 16:02:11
- Reporting Period:
- 2019-10-28
- Accepted Time:
- 2019-10-30 16:02:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1654151 | Deciphera Pharmaceuticals Inc. | DCPH | Pharmaceutical Preparations (2834) | 200299725 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1713712 | Lee Daniel Flynn | C/O Deciphera Pharmaceuticals, Inc. 500 Totten Pond Road Waltham MA 02451 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-10-28 | 29,820 | $1.89 | 54,320 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-10-28 | 29,820 | $40.00 | 24,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-10-28 | 29,820 | $0.00 | 29,820 | $1.89 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 319,751 | 2025-12-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 66,779 | Indirect | By Daniel L. Flynn Irrevocable Trust |
| Common Stock | 55,270 | Indirect | By Biochenomix, LLC |
Footnotes
- The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015.
Billionaire Hedge Funds
